Invention Application
- Patent Title: FORMULATIONS AND PROCESSES FOR CAR T CELL DRUG PRODUCTS
-
Application No.: US17592105Application Date: 2022-02-03
-
Publication No.: US20220241329A1Publication Date: 2022-08-04
- Inventor: Muneeswara Babu MEDI , Zhuojin XU , Jung S. LEE , Yajin NI , Mark W. LEONARD
- Applicant: Allogene Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Allogene Therapeutics, Inc.
- Current Assignee: Allogene Therapeutics, Inc.
- Current Assignee Address: US CA South San Francisco
- Main IPC: A61K35/17
- IPC: A61K35/17 ; A01N1/02 ; C12N5/0783
Abstract:
Provided herein are formulations and drug product processes that can improve cell viability and minimize waste of the manufactured formulated cells for a drug product.
Public/Granted literature
- US12295362B2 Formulations and processes for CAR T cell drug products Public/Granted day:2025-05-13
Information query
IPC分类:
